by danka | Sep 11, 2023 | Speakers Biosimilars LatAm - Europe 2023
CEVAP-UNESP, Brazil Main Researcher Senior Researcher CEVAP-UNESP. Full Lecturer in Venomous Animals: Accidents and Toxins. Graduated in Veterinary Medicine (UNESP), Master and PhD in Tropical Diseases (School of Medicine – UNESP), Post-doctorate in Immunochemistry at...
by danka | Aug 29, 2023 | Speakers Biosimilars LatAm - Europe 2023
IQVIA, Austria Thought Leadership Consultant Stefan has over 8 years of experience working in academia and life sciences. He joined the thought leadership team in June 2021 where he creates content relevant to pharma executives and publishes articles, blogs, and white...
by danka | Aug 25, 2023 | Speakers Biosimilars LatAm - Europe 2023
Biosidus, Spain Director of Africa, Middle East & Euroasia Roberto has been working in the pharmaceutical industry with a focus on Biosimilars during the last 25 years. He already developed businesses and projects in the field of Biosimilars in more than 50...
by danka | Aug 19, 2023 | Speakers Biosimilars LatAm - Europe 2023, Speakers Biosimilars LatAm - Europe 2024
Business Consultant Pharmaceuticals Former STADA, Germany Elif Ülkü is a pharmaceutical professional with 6+ years experience in the Specialty Care and Biosimilars industry, having worked in business development, commercial, supply chain, innovation and strategy...
by danka | Aug 19, 2023 | Speakers Biosimilars LatAm - Europe 2023
Merck Group, Switzerland Previous Program Leader Biosimilars Partnership, Global Strategic Excellence – Business Operations & Strategy Marina has been working in the pharmaceutical industry for almost two decades. She has worked with MSD, Sandoz, Novartis,...
by danka | Aug 19, 2023 | Speakers Biosimilars LatAm - Colombia 2024, Speakers Biosimilars LatAm - Europe 2023
Sr. Director Corporate Affairs & Market Access LATAM at Teva Pharmaceuticals, Chile Vice-Chair of the International Trade and Intellectual Property Committee at IGBA Pharmaceutical industry executive with over 17 years of experience in complex negotiations and...
